Volume 10, Issue 9 pp. 768-770
Research Letter

Antidiabetic medication de-escalation following bariatric surgery

减肥手术之后可以降级使用降糖药物

Scott M. Vouri

Scott M. Vouri

St. Louis College of Pharmacy, Department of Pharmacy Practice, St. Louis, Missouri, USA

St. Louis College of Pharmacy, Center for Health Outcomes Research and Education, St. Louis, Missouri, USA

Search for more papers by this author
Jiajing Chen

Jiajing Chen

Center for Outcomes Research, Saint Louis University, St. Louis, Missouri, USA

Search for more papers by this author
Jayme Sparkman

Jayme Sparkman

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA

Search for more papers by this author
Arghavan Salles

Arghavan Salles

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA

Search for more papers by this author
Scott T. Micek

Corresponding Author

Scott T. Micek

St. Louis College of Pharmacy, Department of Pharmacy Practice, St. Louis, Missouri, USA

St. Louis College of Pharmacy, Center for Health Outcomes Research and Education, St. Louis, Missouri, USA

Correspondence

Scott T. Micek, St. Louis College of Pharmacy, 4588 Parkview Place, St. Louis, MO 63110, USA.

Tel: +1 314 446 8435

Fax: +1 314 446 8136

Email: [email protected]

Search for more papers by this author
First published: 07 May 2018
Citations: 3

Abstract

Highlights

  • There is a de-escalation of antidiabetes medications prescribed following bariatric surgery.
  • Antidiabetes medication utilization following bariatric surgery does not appear to be consistent with clinical practice guidelines.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.